CONMED CORPORATION Business Combination, Acquisition Related Costs
CONMED CORPORATION (CNMD) reported Business Combination, Acquisition Related Costs of $600.00 thousand for the 3-month period ending 2020-12-31, per its 10-K filed 2021-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2021-02-22
- CONMED CORPORATION business combination, acquisition related costs for the quarter ending 2020-12-31 was $600.00K, a 68.42% decline year-over-year.
- CONMED CORPORATION business combination, acquisition related costs for the quarter ending 2020-09-30 was $800.00K, a 52.94% decline year-over-year.
- CONMED CORPORATION business combination, acquisition related costs for the quarter ending 2020-06-30 was $1.10M, a 63.33% decline year-over-year.
- CONMED CORPORATION business combination, acquisition related costs for the quarter ending 2020-03-31 was $1.60M, a 79.75% decline year-over-year.
- CONMED CORPORATION business combination, acquisition related costs for fiscal 2018 was $1.10M.
- CONMED CORPORATION business combination, acquisition related costs for fiscal 2011 was $300.00K.
- CONMED CORPORATION business combination, acquisition related costs for fiscal 2010 was $0.00.
- CONMED CORPORATION business combination, acquisition related costs for fiscal 2009 was $0.00.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 3 month as first filed | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 9 month as first filed | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | $600.00K 10-K · filed 2021-02-22 | $1.40M derived: sum of 2 quarters · filed 2021-02-22 | $2.50M derived: sum of 3 quarters · filed 2021-02-22 | $4.10M derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2020-09-30 | $800.00K 10-K · filed 2021-02-22 | $1.90M derived: sum of 2 quarters · filed 2021-02-22 | $3.50M derived: sum of 3 quarters · filed 2021-02-22 | $5.40M derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2020-06-30 | $1.10M 10-K · filed 2021-02-22 | $2.70M derived: sum of 2 quarters · filed 2021-02-22 | $4.60M derived: sum of 3 quarters · filed 2021-02-22 | $6.30M derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2020-03-31 | $1.60M 10-K · filed 2021-02-22 | $3.50M derived: sum of 2 quarters · filed 2021-02-22 | $5.20M derived: sum of 3 quarters · filed 2021-02-22 | $8.20M derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2019-12-31 | $1.90M 10-K · filed 2021-02-22 | $3.60M derived: sum of 2 quarters · filed 2021-02-22 | $6.60M derived: sum of 3 quarters · filed 2021-02-22 | $14.50M derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2019-09-30 | $1.70M 10-K · filed 2021-02-22 | $4.70M derived: sum of 2 quarters · filed 2021-02-22 | $12.60M derived: sum of 3 quarters · filed 2021-02-22 | $13.90M derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2019-06-30 | $3.00M 10-K · filed 2021-02-22 | $10.90M derived: sum of 2 quarters · filed 2021-02-22 | $12.20M derived: sum of 3 quarters · filed 2021-02-22 | $13.30M derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2019-03-31 | $7.90M 10-K · filed 2021-02-22 | $9.20M derived: sum of 2 quarters · filed 2021-02-22 | $10.30M derived: sum of 3 quarters · filed 2021-02-22 | |||
| 2018-12-31 | $1.30M 10-K · filed 2020-02-24 | $2.40M derived: sum of 2 quarters · filed 2020-02-24 | $1.10M 10-K · filed 2021-02-22 | |||
| 2018-09-30 | $1.10M 10-K · filed 2020-02-24 | |||||
| 2014-09-30 | $300.00K 10-Q · filed 2015-10-23 | $334.00K 10-Q · filed 2014-10-24 | $400.00K 10-Q · filed 2015-10-23 | $444.00K 10-Q · filed 2014-10-24 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-24 | $0.00 10-Q · filed 2014-10-24 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $0.00 derived: sum of 2 quarters · filed 2012-10-29 | $704.00K 10-Q · filed 2012-10-29 | $1.00M derived: sum of 4 quarters · filed 2012-10-29 | ||
| 2012-06-30 | $0.00 10-Q · filed 2012-07-30 | $704.00K 10-Q · filed 2012-07-30 | $1.00M derived: sum of 3 quarters · filed 2012-07-30 | |||
| 2012-03-31 | $704.00K 10-Q · filed 2012-05-01 | $1.00M derived: sum of 2 quarters · filed 2012-05-01 | ||||
| 2011-12-31 | $300.00K 10-K · filed 2012-02-28 | $300.00K 10-K · filed 2012-02-28 | ||||
| 2011-06-30 | $0.00 10-Q · filed 2012-07-30 | $0.00 10-Q · filed 2012-07-30 | ||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-01 | |||||
| 2010-12-31 | $0.00 10-K · filed 2012-02-28 | |||||
| 2009-12-31 | $0.00 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |